NCT02120040View on ClinicalTrials.gov

Psychosocial Consequences of the Screening of Von Hippel Lindau Diseases for Patients Operated for a hémangioblastoma of Nervous Centrasl System

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

May 2, 2014

Primary Completion Date

October 9, 2015

Study Completion Date

March 8, 2023

Conditions
Hemangioblastoma (HB) of the Central Nervous System (CNS)
Interventions
OTHER

evaluation of anxiety with psychosocial scales

Trial Locations (1)

13005

Assistance Publique Hopitaux de Marseille, Marseille

All Listed Sponsors
lead

Assistance Publique Hopitaux De Marseille

OTHER

NCT02120040 - Psychosocial Consequences of the Screening of Von Hippel Lindau Diseases for Patients Operated for a hémangioblastoma of Nervous Centrasl System | Biotech Hunter | Biotech Hunter